Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication.
about
Differences in Clinical Manifestations according to the Positivity of Interferon-γ Assay in Patients with Intestinal Tuberculosis.Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.Characterisation of Clostridium difficile strains isolated from Groote Schuur Hospital, Cape Town, South Africa.
P2860
Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Incidence and Clinical Outcome ...... with Tuberculosis Medication.
@ast
Incidence and Clinical Outcome ...... with Tuberculosis Medication.
@en
type
label
Incidence and Clinical Outcome ...... with Tuberculosis Medication.
@ast
Incidence and Clinical Outcome ...... with Tuberculosis Medication.
@en
prefLabel
Incidence and Clinical Outcome ...... with Tuberculosis Medication.
@ast
Incidence and Clinical Outcome ...... with Tuberculosis Medication.
@en
P2093
P2860
P356
P1433
P1476
Incidence and Clinical Outcome ...... with Tuberculosis Medication.
@en
P2093
Byung Ik Jang
Daejeon-Chungchung Intestinal Research Group
Hee Seok Moon
Hoon Sup Koo
Jeong Eun Shin
Kyu Chan Huh
Sae Hee Kim
Seung Woo Lee
Soon Man Yoon
P2860
P304
P356
10.5009/GNL14435
P50
P577
2015-08-11T00:00:00Z